All community pharmacy articles
-
PHE/DH/DWP guidelinePHE management of staff exposure to COVID-19
This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
PHE/DH/DWP guideline
PHE flu immunisation 2021–2022 guideline
This Guidelines summary covers key information on the 2021–2022 flu immunisation programme
-
News
This is the golden hour for community pharmacy
Leyla Hannbeck calls for greater government collaboration and support in response to the vital role that community pharmacy has played in frontline healthcare during the COVID-19 pandemic
-
Independent professional body guideline
BSPID/EFP oral health and pregnancy guideline
A short, useful summary of key oral health recommendations for pregnant women from the British Society of Periodontology
-
Independent professional body guideline
BSPID gum disease and diabetes guideline
A short overview of periodontal (gum disease) and its links with diabetes, including advice for community pharmacy teams
-
Independent professional body guideline
Self Care Forum venous disease fact sheet
A summary of recommendations for advising patients and the public on managing venous disease
-
Independent professional body guideline
GINA strategy 2021: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11
-
Independent professional body guideline
PCDS hyperhidrosis guideline
An easy-to-read summary of Primary Care Dermatology Society guidance on investigations for, and management of, excessive sweating
-
NICE guideline
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
-
NHS guideline
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
NICE guideline
NICE CKS on chickenpox
Management of chickenpox in healthy children and adults, during pregnancy and breastfeeding, and in people who are immunocompromised
-
NICE guideline
NICE CKS on common cold
A useful summary for community pharmacists covering diagnosis, management, and prescribing information in adults, children, and young people
-
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
NICE guideline
NICE CKS on rosacea
A summary of guidance to assist healthcare professionals on the diagnosis and management of rosacea
-
News
PHE publishes new guidance on managing COVID-19 variants of concern
Amid concerns around the spread of new COVID-19 variants, PHE has published guidance for identifying and managing possible or confirmed cases
-
News
UK government publishes largest ever vaccination delivery plan
The British government has set out a plan that aims to vaccinate millions of people against COVID-19 by the spring
